Assessment of adherence to highly active antiretroviral therapy in a cohort of African HIV-infected children in Abidjan, Côte d'Ivoire

Journal of Acquired Immune Deficiency Syndromes

Volumn 40, Issue 4, 2005, Pages 498-500

  Elise, Arrivé ^a   France, Anaky Marie ^b   Louise, Wemin Marie ^c   Bata, Diabate ^b   François, Rouet ^c   Roger, Salamon ^a   Philippe, Msellati ^d  

^a Institut de Santé Publique d'Epidémiologie et de Développement ISPED   (France)

^b Projet Enfant   (Côte d’Ivoire)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Adherence; Africa; Children; Highly active antiretroviral therapy; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ANTIVIRAL ACTIVITY; ARTICLE; CAREGIVER; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE ACCESS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT COMPLIANCE; PATIENT INFORMATION; PRIORITY JOURNAL; RECALL; RISK ASSESSMENT; SCORING SYSTEM; VIRUS LOAD;

ADOLESCENT; AGE FACTORS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COTE D'IVOIRE; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; OXAZINES; PATIENT COMPLIANCE; TREATMENT REFUSAL; VIRAL LOAD;

EID: 27944491926     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000168180.76405.5f     Document Type: Article

References (15)

1. Tanuri A, Caridea E, Dantas MC, et al. Prevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAART. J Clin Virol. 2002;25:39-46.
2. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
3. Sethi AK, Celentano DD, Gange SJ, et al. Association between adherence to antiretroviral therapy and HIV drug resistance. Clin Infect Dis. 2003;37:1112-1118.
4. Van Dyke RB, Lee S, Johnson GM, et al. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection. Pediatrics. 2002;109:e61.
5. Reddington C, Cohen J, Baldillo A, et al. Adherence to medication regimens among children with human immunodeficiency virus infection. Pediatr Infect Dis J. 2000;19:1148-1153.
6. Mellins CA, Brackis-Cott E, Dolezal C, et al. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23:1035-1041.
7. Fassinou P, Elenga N, Rouet F, et al. Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire. AIDS. 2004;18: 1905-1913.
8. Rouet F, Msellati P, Coulibaly N, et al. Antiretroviral treatment monitoring of children with plasma HIV-1 RNA quantitative real-time PCR assay: a very attractive alternative in resource-poor settings. Abstract 1093. Paper presented at: Second International AIDS Society Conference on HIV Pathogenesis and treat ment; July 13-17, 2003; Paris.
9. Eley B, Nuttall J, Davies MA, et al. Initial experience of a public sector antiretroviral treatment programme for HIV-infected children and their infected parents. S Afr Med J. 2004;94:643-646.
10. Zeguela B. M édicaments antirétroviraux: rupture de deux molécules, les VIH+ menacent. Fraternité Matin June 2003. Available at: http://www. essentialdrugs.org/emed/archive/200306/msg00068.php. Accessed April 2005.
11. Farley J, Gona P, Crain M, et al. Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C. J Acquir Immune Defic Syndr. 2005;38:480-487.
12. Kalyebara J, Barigye H. Children and adherence [P315]. Paper presented at: Sixth International Congress on Drug Therapy in HIV Infection; November 17-21, 2002; Glasgow, UK.
13. Farley J, Hines S, Musk A, et al. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr. 2003;33:211-218.
14. Giordano TP, Guzman D, Clark R, et al. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5:74-79.
15. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36:1100-1102.